📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Rituximab causes a polarization of B cells that augments its therapeutic function in NK-cell-mediated antibody-dependent cellular cytotoxicity. (2013)

First Author: Rudnicka D

Attributed to: Drug Delivery at the Immunological Synapse funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2013-02-482570

PubMed Identifier: 23613524

Publication URI: http://europepmc.org/abstract/MED/23613524

Type: Journal Article/Review

Volume: 121

Parent Publication: Blood

Issue: 23

ISSN: 0006-4971